BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11739389)

  • 1. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration.
    Swertfeger DK; Bu G; Hui DY
    J Biol Chem; 2002 Feb; 277(6):4141-6. PubMed ID: 11739389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A.
    Zhu Y; Hui DY
    J Biol Chem; 2003 Sep; 278(38):36257-63. PubMed ID: 12857755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation.
    Swertfeger DK; Hui DY
    J Biol Chem; 2001 Jul; 276(27):25043-8. PubMed ID: 11350966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation.
    Zeleny M; Swertfeger DK; Weisgraber KH; Hui DY
    Biochemistry; 2002 Oct; 41(39):11820-3. PubMed ID: 12269825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase.
    Ishigami M; Swertfeger DK; Hui MS; Granholm NA; Hui DY
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1020-6. PubMed ID: 10764667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration.
    Li Y; Lu W; Bu G
    FEBS Lett; 2003 Dec; 555(2):346-50. PubMed ID: 14644440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.
    Wilsie LC; Gonzales AM; Orlando RA
    Lipids Health Dis; 2006 Aug; 5():23. PubMed ID: 16945147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase.
    Ishigami M; Swertfeger DK; Granholm NA; Hui DY
    J Biol Chem; 1998 Aug; 273(32):20156-61. PubMed ID: 9685360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ; van Dijk KW; van't Hof HB; van Gorp PJ; van der Zee A; van der Boom H; Breuer ML; Hofker MH; Havekes LM
    J Biol Chem; 1996 Nov; 271(48):30595-602. PubMed ID: 8940032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein.
    Narita M; Holtzman DM; Fagan AM; LaDu MJ; Yu L; Han X; Gross RW; Bu G; Schwartz AL
    J Biochem; 2002 Nov; 132(5):743-9. PubMed ID: 12417024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E.
    Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F
    Biol Reprod; 1999 Nov; 61(5):1216-25. PubMed ID: 10529267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
    Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23.
    Gåfvels ME; Caird M; Britt D; Jackson CL; Patterson D; Strauss JF
    Somat Cell Mol Genet; 1993 Nov; 19(6):557-69. PubMed ID: 8128315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae.
    Boucher P; Liu P; Gotthardt M; Hiesberger T; Anderson RG; Herz J
    J Biol Chem; 2002 May; 277(18):15507-13. PubMed ID: 11854295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
    Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
    Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.
    Sheng Z; Prorok M; Brown BE; Castellino FJ
    Neuropharmacology; 2008 Aug; 55(2):204-14. PubMed ID: 18602124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.
    Kozaki K; Kaminski WE; Tang J; Hollenbach S; Lindahl P; Sullivan C; Yu JC; Abe K; Martin PJ; Ross R; Betsholtz C; Giese NA; Raines EW
    Am J Pathol; 2002 Oct; 161(4):1395-407. PubMed ID: 12368212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.
    Calvier L; Herz J; Hansmann G
    JACC Basic Transl Sci; 2022 Feb; 7(2):164-180. PubMed ID: 35257044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low density lipoprotein receptor-related protein-1 on the expression of platelet-derived growth factor beta-receptor in vitro.
    Wu L; Arandjelovic S; Gonias SL
    J Cell Biochem; 2004 Dec; 93(6):1169-77. PubMed ID: 15486970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.